Transcriptional control of Borna disease virus (BDV) in persistently BDV-infected cells

被引:10
作者
Mizutani, T
Inagaki, H
Hayasaka, D
Shuto, S
Minakawa, N
Matsuda, A
Kariwa, H
Takashima, I
机构
[1] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Publ Hlth Lab,Kita Ku, Sapporo, Hokkaido 0600818, Japan
[2] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan
关键词
D O I
10.1007/s007050050716
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Regulation of viral RNA levels in infected cells is considered important in the investigation of viral transcription and replication. Amounts of Borna disease virus (BDV) RNAs were increased in confluent persistently BDV-infected MDCK cells (MDCK/BDV) cells, while maintained at low levels in growing cells. The amount of 1.9-kb RNA without cap formation and polyadenylation at the 5' and 3' ends respectively were remarkably increased (200% per day) in confluent MDCK/BDV cells. Both the full-length genomic and anti-genomic RNAs were increased accompained by 1.9-kb RNA, suggesting the transcription of the 1.9-kb RNA was important for replication of BDV. Ribavirin has an inhibitory effect on replication and transcription of BDV at concentrations from 1 to 10 mu g/ml [Mizutani T et al., Arch Virol (1998) 143: 2039-2044]. BDV transcripts were decreased with ribavirin treatment and increased after its removal which indicated that ribavirin has a reversible inhibitory effect on BDV transcription. Furthermore, BDV transcription was also decreased by two agents, RMNPA and EICAR, which selectively inhibit enzyme activity related to cap formation at the 5' end of mRNA. On the contrary, when the growing MDCK/BDV cells were treated with actinomycin D, transcripts of BDV RNA were increased for 24 h. These agents and culture conditions in this study were found to be useful tools for up-and down-regulation of BDV transcription in persistently BDV-infected cells.
引用
收藏
页码:1937 / 1946
页数:10
相关论文
共 24 条
[1]   GENE-EXPRESSION OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES [J].
BANERJEE, AK ;
BARIK, S ;
DE, BP .
PHARMACOLOGY & THERAPEUTICS, 1991, 51 (01) :47-70
[2]   HUMAN INFECTIONS WITH BORNA DISEASE VIRUS - SEROPREVALENCE IN PATIENTS WITH CHRONIC DISEASES AND HEALTHY-INDIVIDUALS [J].
BODE, L ;
RIEGEL, S ;
LANGE, W ;
LUDWIG, H .
JOURNAL OF MEDICAL VIROLOGY, 1992, 36 (04) :309-315
[3]   GENOMIC ORGANIZATION OF BORNA-DISEASE VIRUS [J].
BRIESE, T ;
SCHNEEMANN, A ;
LEWIS, AJ ;
PARK, YS ;
KIM, S ;
LUDWIG, H ;
LIPKIN, WI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4362-4366
[4]   LEADER SEQUENCE DISTINGUISHES BETWEEN TRANSLATABLE AND ENCAPSIDATED MEASLES-VIRUS RNAS [J].
CASTANEDA, SJ ;
WONG, TC .
JOURNAL OF VIROLOGY, 1990, 64 (01) :222-230
[5]  
Clercq E.D., 1991, ANTIMICROB AGENTS CH, V35, P679, DOI DOI 10.1007/s00109-001-0308-0
[6]   SEQUENCE AND GENOME ORGANIZATION OF BORNA-DISEASE VIRUS [J].
CUBITT, B ;
OLDSTONE, C ;
DELATORRE, JC .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1382-1396
[7]   BORNA-DISEASE VIRUS (BDV), A NONSEGMENTED RNA VIRUS, REPLICATES IN THE NUCLEI OF INFECTED-CELLS WHERE INFECTIOUS BDV RIBONUCLEOPROTEINS ARE PRESENT [J].
CUBITT, B ;
DELATORRE, JC .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1371-1381
[8]   Detection of borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients [J].
DelaTorre, JC ;
GonzalezDunia, D ;
Cubitt, B ;
Mallory, M ;
MuellerLantzsch, N ;
Grasser, FA ;
Hansen, LA ;
Masliah, E .
VIROLOGY, 1996, 223 (02) :272-282
[9]   INHIBITION OF INFLUENZA-VIRUS RIBONUCLEIC-ACID POLYMERASE BY RIBAVIRIN TRIPHOSPHATE [J].
ERIKSSON, B ;
HELGSTRAND, E ;
JOHANSSON, NG ;
LARSSON, A ;
MISIORNY, A ;
NOREN, JO ;
PHILIPSON, L ;
STENBERG, K ;
STENING, G ;
STRIDH, S ;
OBERG, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (06) :946-951
[10]  
Gellert M, 1995, Tierarztl Prax, V23, P207